(HealthDay)—Early therapeutic anticoagulation does not appear to affect survival among critically ill adults with COVID-19, according to a study published online Jan. 26 in the Annals of Internal Medicine. Hanny...

People in menopause experiencing upsetting stressful events are more likely to have worsened menopause symptoms—and the level of social support they receive doesn’t seem to moderate the impact...

Two large studies give a much sharper picture of which inherited mutations raise the risk of breast cancer for women without a family history of the disease, and how common these flawed genes are in the...

The most severe cases of COVID-19 begin with leaky blood vessels. Breaches in the vascular system cause inflammation and coagulation, as fluid floods the lungs. Meanwhile, a host of seemingly unrelated...

Why Dr. Siegel is ‘very excited’ about Johnson & Johnson’s COVID-19 vaccine J&J’s ‘robust’ coronavirus vaccine generates a lasting immune response in...

Antibodies against the novel coronavirus may not work as well against a new variant of the virus identified in South Africa, early data suggest. Scientists recently raised concerns that the variant, known...

Serious allergic reactions after  COVID-19 vaccines are likely more common than serious reactions following flu vaccines, but are still very rare, according to a new report. The report authors, from the...

A novel form of a drug used to treat osteoporosis that comes with the potential for fewer side effects may provide a new option for patients. The work is supported by the National Institutes of Health...

Soon after rapamycin, the first mTOR inhibitor, emerged in 1990s as a potential treatment against unwanted cell proliferation, many cancer experts had hoped emerging drugs targeting mTOR would become...

WEDNESDAY, Dec. 16, 2020 — People working from home during the pandemic overall report decreased physical and mental well-being, according to a study published online Nov. 23 in the Journal of Occupational...